326 related articles for article (PubMed ID: 24953629)
1. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.
Bellail AC; Olson JJ; Hao C
Nat Commun; 2014 Jun; 5():4234. PubMed ID: 24953629
[TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
3. [Hypoxia increases chemotherapy resistance in nasopharyngeal carcinoma via inducing CDK6 deSUMOylation].
Ren Q; Liu FT; Zhang CY; Li LL; Cheng RZ; Liu XZ; Liu Q; Zhou HF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):524-528. PubMed ID: 31315360
[No Abstract] [Full Text] [Related]
4. Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity.
Su YF; Yang T; Huang H; Liu LF; Hwang J
PLoS One; 2012; 7(4):e34250. PubMed ID: 22509284
[TBL] [Abstract][Full Text] [Related]
5. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.
Chen SM; Chen HC; Chen SJ; Huang CY; Chen PY; Wu TW; Feng LY; Tsai HC; Lui TN; Hsueh C; Wei KC
World J Surg Oncol; 2013 Apr; 11():87. PubMed ID: 23594394
[TBL] [Abstract][Full Text] [Related]
7. Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo.
Zhou M; Lin F; Xu W; Jin R; Xu A
Mol Med Rep; 2018 Sep; 18(3):3469-3475. PubMed ID: 30066925
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
Akli S; Keyomarsi K
Cancer Biol Ther; 2003; 2(4 Suppl 1):S38-47. PubMed ID: 14508079
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
11. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
12. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
13. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases.
Pandey D; Chen F; Patel A; Wang CY; Dimitropoulou C; Patel VS; Rudic RD; Stepp DW; Fulton DJ
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1634-42. PubMed ID: 21527745
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.
Wen D; Wu J; Wang L; Fu Z
Cell Rep; 2017 Nov; 21(8):2147-2159. PubMed ID: 29166606
[TBL] [Abstract][Full Text] [Related]
15. Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast.
Dieckhoff P; Bolte M; Sancak Y; Braus GH; Irniger S
Mol Microbiol; 2004 Mar; 51(5):1375-87. PubMed ID: 14982631
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth.
Karkare S; Chhipa RR; Anderson J; Liu X; Henry H; Gasilina A; Nassar N; Ghosh J; Clark JP; Kumar A; Pauletti GM; Ghosh PK; Dasgupta B
Clin Cancer Res; 2014 Jan; 20(1):199-212. PubMed ID: 24170547
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
18. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract][Full Text] [Related]
20. RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
Swaminathan S; Kiendl F; Körner R; Lupetti R; Hengst L; Melchior F
J Cell Biol; 2004 Mar; 164(7):965-71. PubMed ID: 15037602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
